Author | Matthew D. Hellmann, MD | OncLive

Author | Matthew D. Hellmann, MD

Articles

Dr. Hellmann on Tumor Mutational Burden Testing in Patients With Lung Cancer

May 12, 2018

Video

Matthew D. Hellmann, MD, assistant attending physician, Memorial Sloan Kettering Cancer Center, discusses the process of tumor mutational burden (TMB) testing in patients with lung cancer.

Dr. Hellmann on Tumor Mutational Burden in NSCLC

April 18, 2018

Video

Matthew D. Hellmann, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the role tumor mutational burden (TMB) plays in determining combination therapies for patients with non–small cell lung cancer (NSCLC).

Dr. Hellmann on the Design of the CheckMate-032 Study for Lung Cancer

July 13, 2017

Video

Matthew D. Hellmann, MD, Memorial Sloan Kettering Cancer Center, discusses the design of the CheckMate-032 study investigating nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).

Dr. Hellmann on Nivolumab in Combination with Ipilimumab for Small Cell Lung Cancer

June 20, 2017

Video

Matthew D. Hellmann, MD, Memorial Sloan Kettering Cancer Center, discusses the CheckMate-032 study investigating nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).

x